JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.4
13.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
JiangSu WuZhong Pharmaceutical Development Co Ltd
JiangSu WuZhong Pharmaceutical Development Co Ltd
Cash & Cash Equivalents
JiangSu WuZhong Pharmaceutical Development Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
|
Cash & Cash Equivalents
¥1.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
25%
|
CAGR 10-Years
12%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash & Cash Equivalents
¥22.4B
|
CAGR 3-Years
74%
|
CAGR 5-Years
103%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash & Cash Equivalents
¥8.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
16%
|
CAGR 10-Years
23%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash & Cash Equivalents
¥22.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
41%
|
CAGR 10-Years
22%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash & Cash Equivalents
¥14.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
24%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Cash & Cash Equivalents
¥391.7m
|
CAGR 3-Years
105%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
JiangSu WuZhong Pharmaceutical Development Co Ltd
Glance View
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. engages in the research and development, production and sales of pharmaceuticals, organic pigments, dyes and their intermediates. The company is headquartered in Suzhou, Jiangsu and currently employs 1,067 full-time employees. The firm's business includes pharmaceuticals, chemicals and real estate. Pharmaceutical business mainly involves pharmaceutical research, development, manufacture and sales. Chemical business mainly includes research, development, manufacture and sales of organic pigments, dyes and intermediates. Its main production varieties are used to produce reactive dyes and organic pigments. Real estate business includes commercial housing and affordable housing.
See Also
What is JiangSu WuZhong Pharmaceutical Development Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.7B
CNY
Based on the financial report for Sep 30, 2024, JiangSu WuZhong Pharmaceutical Development Co Ltd's Cash & Cash Equivalents amounts to 1.7B CNY.
What is JiangSu WuZhong Pharmaceutical Development Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
12%
Over the last year, the Cash & Cash Equivalents growth was -48%. The average annual Cash & Cash Equivalents growth rates for JiangSu WuZhong Pharmaceutical Development Co Ltd have been 15% over the past three years , 25% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
